Preliminary trial of cyclophosphamide in the management of hemophiliacs with factor VIII inhibitors.
D000293:Adolescent; D000328:Adult; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D001792:Blood Platelets; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005169:Factor VIII / Q000037:antagonists & inhibitors; D005998:Glycine / Q000627:therapeutic use; D006410:Hematopoiesis / Q000187:drug effects; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology; D006470:Hemorrhage / Q000188:drug therapy; D006801:Humans; D007156:Immunologic Memory; D007958:Leukocyte Count; D008297:Male
D000906:Antibodies; D003520:Cyclophosphamide; D005169:Factor VIII; D005998:Glycine